Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · IEX Real-Time Price · USD
8.79
+0.45 (5.40%)
At close: May 2, 2024, 4:00 PM
8.81
+0.02 (0.23%)
After-hours: May 2, 2024, 7:55 PM EDT
Recursion Pharmaceuticals Revenue
In the year 2023, Recursion Pharmaceuticals had annual revenue of $44.58M with 11.88% growth. Revenue in the quarter ending December 31, 2023 was $10.89M, a -20.36% decrease year-over-year.
Revenue (ttm)
$44.58M
Revenue Growth
+11.88%
P/S Ratio
45.38
Revenue / Employee
$89,150
Employees
500
Market Cap
2.02B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.58M | 4.73M | 11.88% |
Dec 31, 2022 | 39.84M | 29.67M | 291.46% |
Dec 31, 2021 | 10.18M | 6.22M | 156.89% |
Dec 31, 2020 | 3.96M | 1.64M | 70.85% |
Dec 31, 2019 | 2.32M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
agilon health | 4.32B |
Amneal Pharmaceuticals | 2.39B |
UFP Technologies | 400.07M |
Galapagos NV | 266.36M |
Agios Pharmaceuticals | 26.82M |
NewAmsterdam Pharma Company | 15.66M |
Avidity Biosciences | 9.56M |
RXRX News
- 18 hours ago - Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9 - GlobeNewsWire
- 1 day ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 11 days ago - Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX - Invezz
- 16 days ago - Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer - GlobeNewsWire
- 5 weeks ago - Recursion Publishes Annual Environmental, Social and Governance Report - GlobeNewsWire
- 6 weeks ago - Not just Soundhound, these AI stocks are also riding Nvidia wave - Invezz
- 7 weeks ago - Recursion Announces Plans to Open New Office in London - GlobeNewsWire
- 2 months ago - Recursion Hosts Second Annual Rare Disease Day Events for Utah's Rare Disease Community - GlobeNewsWire